[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.1557-1561
[1]Patent:US2017/121277,2017,A1.Locationinpatent:Paragraph0047-0048
72802-25-6 | 1-(3-Fluoro-4-nitrophenyl)ethanone | AA005OY2 | MFCD13194365
154016-47-4 | (5-Phenylisoxazol-3-yl)methanamine | AA007GRL | MFCD06738927
81759-25-3 | Di(pyrrolidin-1-yl)methanone | AA008LGE | MFCD00216641
1206981-34-1 | Methyl 8-chloroimidazo[1,2-a]pyrazine-2-carboxylate | AA00958L | MFCD20040077
1415314-22-5 | 6-Chloro-8-iodo-[1,2,4]triazolo[1,5-a]pyridine | AA009W4G | MFCD28142353
143979-44-6 | 1-(tert-Butoxycarbonyl)-3-phenylpyrrolidine-2-carboxylic acid | AA00AP8F | MFCD06738936
42287-48-9 | (R,R)-(+)-BIS(ALPHA-METHYLBENZYL)AMINE HYDROCHLORIDE | AA00BYX8 | MFCD00216672
33873-09-5 | 2,6-Difluoropyrazine | AA00CUD1 | MFCD15144300
519059-03-1 | 3-(Difluoromethoxy)phenylacetylene | AA00DTWA | MFCD03094334
682-91-7 | Ethylicin | AA00FA0R | MFCD00186673